John F. Neylan
2016
In 2016, John F. Neylan earned a total compensation of $1M as Chief Medical Officer at Keryx Biopharmaceuticals, a 38% decrease compared to previous year.
Compensation breakdown
| Bonus | $11,100 |
|---|---|
| Non-Equity Incentive Plan | $140,080 |
| Option Awards | $251,765 |
| Salary | $413,061 |
| Stock Awards | $180,063 |
| Other | $4,592 |
| Total | $1,000,681 |
Neylan received $413.1K in salary, accounting for 41% of the total pay in 2016.
Neylan also received $11.1K in bonus, $140.1K in non-equity incentive plan, $251.8K in option awards, $180.1K in stock awards and $4.6K in other compensation.
Rankings
In 2016, John F. Neylan's compensation ranked 8,259th out of 14,075 executives tracked by ExecPay. In other words, Neylan earned more than 41.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,259 out of 14,075 | 41st |
Division Manufacturing | 3,161 out of 5,486 | 42nd |
Major group Chemicals And Allied Products | 1,061 out of 1,900 | 44th |
Industry group Drugs | 826 out of 1,543 | 47th |
Industry Pharmaceutical Preparations | 653 out of 1,173 | 44th |
Source: SEC filing on April 26, 2017.
Neylan's colleagues
We found three more compensation records of executives who worked with John F. Neylan at Keryx Biopharmaceuticals in 2016.